Implantation of the FloWatch® Device and Sepsis: Remove or Wait?

Abstract

Although many reports describe the biological behavior of most prosthetic biomaterials in the presence of infection, little is known about the resistance of the FloWatch® device to internal or external contamination. We report here on our experience with the FloWatch® device in three pediatric patients who contracted persistent sepsis. Good control of infection and complete remission of sepsis were ultimately achieved in all three patients by intensive treatment with antibiotics without removal of the device.

Key words

Congenital heart disease - device - infection - reoperation - antibiotics

References

• 1 Corno A F, Bonnet D, Sekarski N et al. Remote control of pulmonary blood flow: initial clinical experience.  J Thorac Cardiovasc Surg. 2003;  126 1775-1779
• 2 Horan T C, Gaynes R P. Surveillance of nosocomial infections. Appendix A: CDC definitions of nososcomial infections. Mayahall CG Hospital epidemiology and infection control. 3rd edition. Philadelphia; Lippincott Williams and Wilkins 2004: 1659-1702
• 3 Lopez S, Calvinho P, de Oliveira F et al. Allograft aortic root replacement in complex prosthetic endocarditis.  Eur J Cardiothor Surg. 2007;  32 126-132
• 4 Tugtekin S, Matschke K, Daubner D et al. Prosthetic valve endocarditis: importance of surgical treatment.  Thorac Cardiov Surg. 2007;  55 94-98
• 5 Puc M M, Antinori C H, Villanueva D T et al. Ten-year experience with mersilene-reinforced sternal wound closure.  Ann Thor Surg. 2000;  70 97-99